Search For "phase 3 clinical trials"
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
South Korea approves phase 3 clinical trials of breast cancer treatment 'T
Updated : 4 years, 1 month ago IST
Seoul [South Korea], April 19 (ANI/Global Economic): Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea. The clinical trial is a global trial that will be conducted in multiple countries and is expected to be supplied in Korea as
Read More
COVID-19: Nasal vaccine could be a game-changer if it provides mucosal imm
Updated : 4 years, 4 months ago IST
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 5 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 5 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 6 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
First phase 3 clinical trials of South Korean COVID-19 vaccine: Bioscience
Updated : 4 years, 10 months ago IST
Seoul [South Korea], August 11 (ANI/Global Economic): South Korean Bioscience's vaccine for COVID-19 has entered Phase 3 clinical trials for the first time as the vaccine developed in Korea.
Read More
Biological E's COVID-19 vaccine Corbevax likely to be launched by Septembe
Updated : 4 years, 10 months ago IST
New Delhi [India], July 26 (ANI): The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said sources on Monday.
Read More
Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], March 3 (ANI): Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the drug demonstrating 81 per cent interim efficacy against Covid-19.
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clin
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 5 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
US launches Phase 3 trial of 2 new antibody treatments for COVID-19
Updated : 5 years, 5 months ago IST
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two experimental drugs to treat hospitalized COVID-19 patients when combined with existing treatments, said the National Institute for Allergy and Infectious Diseases (NIAID) (local time
Read More